Apollomics Inc. Warrant
N/A
USD
N/A
N/A
...
Chart
Financials
Description
APLMW Company Description
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
APLMW Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view APLMW Smart Score
Score Breakdown
APLMW Company Description
Show More
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of APLMW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by APLMW's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of APLMW in WallStreetBets Daily Discussion
APLMW News
Recent insights relating to APLMW
CNBC Recommendations
Recent picks made for APLMW stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in APLMW
Corporate Flights
Flights by private jets registered to APLMW
Our Analysis